Chinese drug companies are urging the country's Food and Drug Administration to act quickly to replace a supplier for a track-and-trace system there. The FDA recently put its project on hold after companies complained that its contract with a unit of Alibaba Group ($BABA) to design the barcode tracking system gave the Hong Kong-based company an unfair edge as it moves to fulfill its online drug selling ambitions. "I advise the CFDA to introduce a new tracking system with more detailed columns … and please be as quick as possible," Wei Feiyan, board chairwoman of Guangxi-based Huahong Pharmaceutical and a deputy to National People's Congress, said at an annual legislative meeting of Chinese leadership where health policy was discussed. More from FiercePharmaAsia
> The FDA has issued a warning letter against compounder Chemolee Lab in Irving, TX. Letter
> San Diego, CA-based Ajinomoto Althea is hiring at least 50 people to staff a second shift at its biologics manufacturing plant. Release
> American Airlines Cargo has added storage space to its pharma cold-chain facilities at the Dallas/Fort Worth airport. Report
> Indonesia has opened its first bonded logistics center which will allow pharmaceutical ingredient makers, and other industries, store products for up to three years without paying taxes. Release